Sfoglia per Titolo
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions
2001-01-01 Pea, F.; Furlanut, M
Pharmacokinetic Behavior of Rituximab: A Study of Different Schedules of Administration for Heterogeneous Clinical Settings
2005-01-01 Regazzi, Mb; Iacona, I; Avanzini, Ma; Arcaini, L; Merlini, G; Perfetti, V; Zaja, Francesco; Montagna, M; Morra, E; Lazzarino, M.
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy
2007-01-01 Pea, F; Viale, P; Pavan, F; Furlanut, Mario; Pea, Federico
Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures
2017-01-01 De Biase, Stefano; Valente, Mariarosaria; Gigli, Gian Luigi; Merlino, Giovanni
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient
2008-01-01 Pea, Federico; Baccarani, Umberto; Tavio, Marcello; Cojutti, Pier Giorgio; Adani, Gian Luigi; Londero, Angela; Baraldo, Massimo; Franceschi, Loretta; Furlanut, Mario; Viale, Pierluigi
Pharmacokinetic evaluation of desogestrel as a female contraceptive
2014-01-01 Grand, i Giovanni; Cagnacci, Angelo; Volpe, Annibale
Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy
2001-01-01 Villani, P; Viale, Pierluigi; Signorini, L; Cadeo, B; Marchetti, F; Villani, A; Fiocchi, C; Regazzi, Mb; Carosi, G.
Pharmacokinetic of protease inhibitors based regimens in 3 liver transplantation HCV/HIV coinfected patients.
2005-01-01 By:adani, Gl; Baccarani, Umberto; Tavio, Marcello; Sainz, Mauricio; Lorenzin, Dario; Pea, Federico; Baraldo, Massimo; Bresadola, Vittorio; Risallti, A; Viale, Pierluigi; Bresadola, Fabrizio
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial
2019-01-01 Undre, Nasrullah; Baccarani, Umberto; Britz, Russel; Popescu, Irinel
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers
1999-01-01 Pea, Federico; Furlanut, Mario; Poz, Donatella; Baraldo, Massimo
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
2015-01-01 Sinnollareddy, Mahipal G.; Roberts, Jason A.; Lipman, Jeffrey; Akova, Murat; Bassetti, Matteo; De Waele, Jan J.; Kaukonen, Kirsi Maija; Koulenti, Despoina; Martin, Claude; Montravers, Philippe; Rello, Jordi; Rhodes, Andrew; Starr, Therese; Wallis, Steven C.; Dimopoulos, George
Pharmacokinetic-pharmacodynamic aspecte of antimicrobial prophylaxis with teisoplanin in patients undergoing major vascular surgery
2006-01-01 Bonardelli, S; Carosi, G; Furlanut, Mario; Giulini, S. M.; Lorenzotti, S; Matheis, A; Pavan, Federica; Pea, Federico; Portolani, N; Signorini, L; Stellini, R; Viale, Pierluigi
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
2015-01-01 Cojutti, P; Maximova, N; Crichiutti, G.; Isola, Miriam; Pea, F.; Pea, Federico
PHARMACOKINETIC/PHARMACODYNAMIC RELATHIONSHIP AND SIMULATION ANALYSIS FOR THE EVALUATION OF ISONIAZID HEPATOTOXICITY RICK DEVELOPMENT IN PATIENTS WITH TUBERCOLOSIS.
2015-01-01 Cojutti, Pier Giorgio; Baraldo, Massimo
Pharmacokinetic/pharmacodynamic relationship and simulation analysis for the evaluation of isoniazid hepatotoxicity risk development in patients with tuberculosis
2015-05-06 Cojutti, Pier Giorgio
Pharmacokinetics (P) of Tamoxifen (T) and related biological variables during long-term adjuvant T theraphy in M0 primary breast cancer (M0PBC)
2001-01-01 G., Cartei; Franceschi, Loretta; M., Furlanut; A., Bertolissi; P. G., Sala; U., Venturelli; G., Tabaro; D., Turrin
Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome.
2011-01-01 Cogo, Paola; Facco, M; Simonato, M; De Luca, D; De Terlizi, F; Rizzotti, U; Verlato, G; Bellagamba, Mp; Carnielli, V. p.
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations
2016-01-01 Torres, Antonio; Mouton, Johan Willem; Pea, Federico
Pharmacokinetics and drug metabolism of antibiotics in the elderly
2018-01-01 Pea, Federico
Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections
2015-01-01 Pai, Manjunath P.; Cojutti, Piergiorgio; Pea, Federico
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile